GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Zomedica Corp.
Zomedica, a veterinary company, is a highly speculative stock. Its price is driven not by stable earnings, but by retail investors' faith in the potential of its diagnostic products for pets.
Share prices of companies in the market segment - Pets
Zomedica is a veterinary company that develops and markets diagnostic products for cats and dogs for use directly in veterinary clinics. We've categorized it as a "Pets" company. The chart below shows how the market rates innovation in the animal health sector.
Broad Market Index - GURU.Markets
Zomedica is a veterinary company that develops and markets diagnostic products for pets. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Zomedica's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
ZOM - Daily change in the company's share price Zomedica Corp.
The daily price change of Zomedica Corp., a veterinary company, reflects volatility in the animal health sector. The metric demonstrates sensitivity to sales of its diagnostic platforms and therapeutic products.
Daily change in the price of a set of shares in a market segment - Pets
Zomedica is a veterinary company that develops and sells diagnostic products for pets. The pet market is considered stable, but competition in the medtech segment is fierce. The chart below shows the average volatility in this industry, which helps assess ZOM's performance.
Daily change in the price of a broad market stock, index - GURU.Markets
Zomedica is a veterinary company that develops and sells diagnostic equipment for animals. The company's stock price reflects rising pet health costs. Its performance is part of a larger picture of a resilient consumer market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Zomedica Corp.
Zomedica Corp.'s year-over-year performance tells the story of its performance in the veterinary diagnostics market. Its market capitalization over the past 12 months reflects its success in selling its TRUFORMA® diagnostic platform and consumables. Its valuation reflects a bet on its products becoming an integral part of veterinary clinics.
Annual dynamics of market capitalization of the market segment - Pets
Zomedica Corp. is a veterinary company that develops and markets diagnostic products for pets. Its stock price is highly volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its innovative technologies, rather than its current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zomedica, a company developing veterinary diagnostic products, operates in the steadily growing pet care market. Its year-over-year market capitalization reflects not so much economic cycles as its success in commercializing its products for veterinary clinics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Zomedica Corp.
Zomedica is a veterinary company commercializing diagnostic products for animals. Its monthly performance reflects the adoption of its TRUFORMA platform in veterinary clinics. Quarterly sales reports are the main drivers.
Monthly dynamics of market capitalization of the market segment - Pets
Zomedica Corp. is a veterinary company specializing in the development and commercialization of diagnostic and therapeutic products for companion animals. Its sector dynamics, shown in the graph, reflect the growing spending on pets. Against this backdrop, one can appreciate how its innovative products, designed for use directly in veterinary clinics, are gaining market share.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zomedica is a company that supplies diagnostic equipment for veterinary medicine. Its shares are driven by news about new product launches and their adoption by veterinary clinics. The chart shows the volatile dynamics typical of companies in the commercialization stage, which are loosely linked to the overall market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Zomedica Corp.
Zomedica, a company developing diagnostic products for veterinary medicine, whose weekly stock price reflects trends in the pet care market. News about the commercialization of its products and partnerships with veterinary clinics drives highly volatile short-term trends.
Weekly dynamics of market capitalization of the market segment - Pets
Zomedica and the entire veterinary diagnostics sector are moving in the wake of the overall trend toward the "humanization" of pets. Rising pet health costs are a driver for everyone. The chart below shows how the company stacks up in this innovative yet competitive market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Zomedica is a veterinary company developing diagnostic products for animals. Demand for pet products is stable. The chart will show whether ZOM shares act as a defensive asset or, as a small company, are more volatile and follow market sentiment.
Market capitalization of the company, segment and market as a whole
ZOM - Market capitalization of the company Zomedica Corp.
Zomedica's stock price is a financial bet on veterinary diagnostics. The market capitalization of this company, which develops diagnostic devices for veterinary clinics, reflects the trend toward the humanization of pets. Its volatility reflects its difficult path to commercialization and competition in the pet health market.
ZOM - Share of the company's market capitalization Zomedica Corp. within the market segment - Pets
Zomedica develops and markets diagnostic products for veterinary medicine. The company's market capitalization in the pet products sector reflects its position in this rapidly growing industry. Zomedica's market capitalization reflects its success in bringing innovative health solutions to cats and dogs.
Market capitalization of the market segment - Pets
Zomedica is a veterinary company that develops and sells diagnostic products for pets. The chart below shows the total market capitalization of the entire pet market. Its steady growth reflects the trend toward the humanization of pets and increasing spending on their health.
Market capitalization of all companies included in a broad market index - GURU.Markets
The pet economy is a multi-billion dollar industry. Zomedica's chart shows how the company, focused on the health of cats and dogs, is fighting for its share of this market. Its market capitalization is a financial reflection of the growing value of veterinary diagnostics and our relationship with our pets.
Book value capitalization of the company, segment and market as a whole
ZOM - Book value capitalization of the company Zomedica Corp.
For Zomedica, a veterinary company, book value is its equity and diagnostic system inventory. The chart below shows its financial and material resources. Its dynamics reflect how the company manages its resources to commercialize animal health products.
ZOM - Share of the company's book capitalization Zomedica Corp. within the market segment - Pets
Zomedica is a veterinary company developing diagnostic products for animals. Its business is the creation and sale of specialized equipment. The asset share chart shows the resources used to manufacture these systems, which are vital for pet health.
Market segment balance sheet capitalization - Pets
Below you can see the overall book value of the healthcare sector. Against this backdrop, Zomedica, which develops diagnostic products for veterinary medicine, is moderately capital-intensive. Its business requires investment in R&D and manufacturing of its devices, making it heavier than pure-play service companies.
Book value of all companies included in the broad market index - GURU.Markets
Zomedica is a veterinary company that develops and markets diagnostic products for pets. The company's assets are not clinics, but a portfolio of diagnostic platforms and intellectual property. The company's balance sheet is the value of the tools that help veterinarians better treat our real, furry family members.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Zomedica Corp.
Zomedica's balance sheet is made up of its cash and diagnostic platforms for veterinarians. Its market capitalization is a bet on its products becoming popular in veterinary clinics. The MvsBCap_Co chart shows how investors value this "dream" relative to the company's actual assets.
Market to book capitalization ratio in a market segment - Pets
Zomedica is a veterinary company developing diagnostic products for cats and dogs. Its value lies in its technology. The chart shows how the market views its TRUFORMA diagnostic platform and its potential to transform the way pets are diagnosed.
Market to book capitalization ratio for the market as a whole
Zomedica is a veterinary company developing diagnostic products for pets. Its valuation is a combination of its bet on the growth of the pet care market and the success of its specific products. The chart shows how much market expectations for veterinary innovation exceed the current value of the company's tangible assets, such as equipment and inventory.
Debts of the company, segment and market as a whole
ZOM - Company debts Zomedica Corp.
For Zomedica, a veterinary diagnostics company, debt is aimed at commercializing its products. This chart shows how the company raises capital for marketing and sales of its diagnostic platforms for veterinary clinics. In this niche, debt is an investment in building a distribution channel and convincing veterinarians of the value of the new technology.
Market segment debts - Pets
Zomedica develops and markets veterinary diagnostic products to improve pet care. The pet care market is growing, but bringing new medical devices to market requires investment. This chart shows how the company funds the development and commercialization of its products in this niche.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Zomedica Corp.
Zomedica is a company developing diagnostic products for veterinary medicine. The pet product market is growing but requires investment in R&D and commercialization. This chart shows how the company is funding its market entry. It provides an indication of the financial risk to achieving profitability in the competitive veterinary industry.
Market segment debt to market segment book capitalization - Pets
Zomedica is a veterinary company that develops and markets diagnostic products for pets (cats and dogs). Bringing new veterinary technologies to market requires investment. The chart shows how the company's debt burden compares to its overall market capitalization and financial standards in the animal health sector.
Debt to book value of all companies in the market
Zomedica (ZOM) develops and sells diagnostic products for the veterinary market, targeting pets. The pet care market is experiencing steady growth. This chart shows the overall debt burden of the economy. It's interesting to analyze how the company manages finances in this promising industry during the commercialization phase.
P/E of the company, segment and market as a whole
P/E - Zomedica Corp.
For Zomedica, a company developing veterinary diagnostic products, this chart is a measure of its commercial potential. A P/E ratio is likely absent. The valuation depends on the success of its products in the market and its ability to compete with established players in the pet health space.
P/E of the market segment - Pets
This chart shows the average P/E ratio for companies operating in the animal health sector. For Zomedica, a veterinary diagnostics company, this is an important benchmark. It helps investors understand how they view its chances of commercial success compared to large, established players in this steadily growing market.
P/E of the market as a whole
Zomedica develops and markets veterinary diagnostic products for use directly in clinics. The pet care market is considered recession-resistant. This chart reflects overall sentiment. It helps understand whether Zomedica's business is truly recession-proof, as people continue to invest in their pets' health.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Zomedica Corp.
Zomedica is a veterinary company that develops and markets diagnostic products for cats and dogs. Future profitability depends on the successful launch of its diagnostic platforms and their adoption by veterinary clinics. This chart shows how confident analysts are in the commercial potential of the company's products in the growing pet care market.
%20P%2FE%20Zomedica%20Corp.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Zomedica-Corp.&v=1772649483892 "Chart of the company's future (projected) P/E Zomedica Corp.")
Future (projected) P/E of the market segment - Pets
Zomedica Corp. develops and markets diagnostic products for the veterinary market, targeting companion animals. This chart shows average expectations for the pet products sector. Zomedica's position may indicate how investors view its product portfolio, the commercial potential of its TRUFORMA diagnostic platform, and its go-to-market strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pets&v=1772649483933 "Future (projected) P/E graph of the market segment - Pets")
Future (projected) P/E of the market as a whole
Zomedica develops diagnostic products for veterinary medicine. The pet care market has historically been resilient to economic downturns. While this chart shows fluctuations in market sentiment, the stable spending by pet owners makes Zomedica's business defensible.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772649483947 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Zomedica Corp.
Zomedica Corp. is a veterinary company that develops and markets diagnostic products for cats and dogs. This chart reflects the growing costs of pet health. Revenue trends will depend on the successful launch of new diagnostic platforms and their adoption by veterinary clinics seeking to improve the quality of care.
Profit of companies in the market segment - Pets
Zomedica Corp. develops and markets diagnostic and therapeutic products for the veterinary market. Profitability in the pet care sector, as this chart shows, is growing thanks to the humanization of pets. For ZOM, the trend toward treating pets as family members means owners are increasingly willing to pay for advanced medical diagnostics and treatments.
Overall market profit
Zomedica Corp., a veterinary company developing diagnostic products for pets, operates in a growing and protective market. Pet owners often spend money on their pets regardless of the state of the economy. This corporate profit curve has little impact on their willingness to care for their pets' health, making Zomedica's business relatively non-cyclical.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Zomedica Corp.
Zomedica is a company developing diagnostic products for veterinary medicine. This chart shows analysts' forecasts for future revenue, which depend on the successful launch and adoption of its diagnostic platforms for cats and dogs by veterinary clinics.
%20profit%20of%20the%20company%20Zomedica%20Corp.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Zomedica-Corp.&v=1772649483979 "Graph of future (projected) profit of the company Zomedica Corp.")
Future (predicted) profit of companies in the market segment - Pets
Zomedica Corp. develops and markets diagnostic and therapeutic products for the veterinary market, targeting companion animals (cats and dogs). The company strives to bring cutting-edge technologies to veterinary medicine. This chart shows the revenue forecast for the pet products sector, reflecting the trend toward "humanization" of pets and rising health care costs.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pets&v=1772649484029 "Graph of future (predicted) profits of companies in a market segment - Pets")
Future (predicted) profit of the market as a whole
Zomedica Corp. develops and markets diagnostic products for veterinary medicine. Pet spending is considered relatively resilient to economic downturns, as owners view their pets as family members. However, a severe recession could force owners to forego expensive diagnostic procedures, posing some risks.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772649484057 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Zomedica Corp.
Zomedica is a veterinary company that sells diagnostic equipment for use in animal clinics. Its revenue comes from sales of these devices and consumables. This chart shows how the market views its commercial success, citing rising pet health costs and the adoption of its technologies by veterinarians.
P/S market segment - Pets
Zomedica Corp. develops and markets diagnostic and therapeutic products for the veterinary market, focusing on companion animals. This chart shows the average revenue estimate for the pet products sector. It helps understand how investors view its product portfolio and potential in the rapidly growing pet care market.
P/S of the market as a whole
Zomedica Corp. develops and markets diagnostic products for the veterinary market, focusing on companion animals. The company aims to bring human medicine technologies to veterinary clinics. This chart helps assess how the market perceives the company's revenue, operating in the growing and recession-resistant pet care market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Zomedica Corp.
Zomedica is a veterinary company that creates diagnostic and therapeutic products for pets. This chart illustrates investor expectations for the growing pet care market. It values the company based on potential future sales of its diagnostic platforms and other products for veterinary clinics.
%20P%2FS%20Zomedica%20Corp.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Zomedica-Corp.&v=1772649484284 "The graph of the company's future (projected) P/S Zomedica Corp.")
Future (projected) P/S of the market segment - Pets
Zomedica Corp. develops and markets veterinary diagnostic products designed for use directly in cat and dog clinics. The data in the chart reflects average market expectations for future sales in the pet products sector. This allows investors to assess the commercial potential of Zomedica's TRUFORMA® diagnostic platform.
%20P%2FS%20market%20segment%20graph%20-%20Pets&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pets&v=1772649484314 "Future (projected) P/S market segment graph - Pets")
Future (projected) P/S of the market as a whole
Zomedica Corp. is a veterinary company developing diagnostic products for pets. The pet care market is a protective and rapidly growing one. This overall revenue expectation is secondary to the company's overall growth. The key driver is the trend toward "humanization" of pets and owners' willingness to invest in their health.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772649484322 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Zomedica Corp.
Zomedica is a veterinary company that commercializes diagnostic products for pets. Its revenue, which you can see in this chart, is generated by sales of diagnostic platforms and consumables to veterinary clinics. Sales growth is a direct indicator of the adoption and use of its technologies in veterinary practice.
Sales of companies in the market segment - Pets
Zomedica Corp. is a veterinary company that develops and commercializes diagnostic products for pets (cats and dogs). Their goal is to provide veterinarians with tools for fast and accurate diagnostics directly in the clinic. This chart shows total revenue in the pet products sector, reflecting the growing costs of pet owners' health care.
Overall market sales
Zomedica is a veterinary company that develops and markets diagnostic products for pets. Demand for its products is driven by veterinary care costs. This total revenue chart reflects the purchasing power that allows pet owners to spend on modern diagnostics and treatments.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Zomedica Corp.
Zomedica Corp. is a veterinary company that develops and markets diagnostic products for pets. Its revenue depends on the commercial success of its TRUFORMA platform and other products for veterinary clinics. This chart shows forecasts for the growth of the diagnostic market for cats and dogs.
%20sales%20of%20the%20company%20Zomedica%20Corp.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Zomedica-Corp.&v=1772649484421 "Schedule of future (projected) sales of the company Zomedica Corp.")
Future (projected) sales of companies in the market segment - Pets
Zomedica Corp. develops and markets veterinary diagnostic products for in-clinic use. The company strives to improve pet care. The chart shows forecasts for the pet products sector. Rising pet spending is a long-term trend supporting Zomedica's business.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pets&v=1772649484431 "Schedule of future (projected) sales of companies in the market segment - Pets")
Future (projected) sales of the market as a whole
Zomedica Corp. develops and markets diagnostic products for veterinary medicine. Demand for its products depends on the willingness of pet owners and veterinary clinics to invest in advanced diagnostics. This trend, reflecting overall consumer confidence, influences spending on pets, which in many families are integral members of the family.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772649484452 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Zomedica Corp.
Zomedica develops and markets veterinary diagnostic products for cats and dogs. Profitability depends on the successful launch of its products and their acceptance by veterinarians. This chart shows the company's journey from research to commercialization in the growing pet care sector.
Market segment marginality - Pets
Zomedica Corp. develops and markets diagnostic and therapeutic products for the veterinary market. This chart shows the average profitability in the pet products sector. The company's ability to exceed this benchmark depends on the successful launch of its innovative products and their adoption by veterinary clinics to improve pet care.
Market marginality as a whole
Zomedica Corp. is a veterinary company that develops and markets diagnostic products for pets (cats and dogs). Its success depends on the adoption of its technologies by veterinary clinics. This total revenue chart helps evaluate how profitable a business focused on the growing pet care market can be compared to other sectors.
Employees in the company, segment and market as a whole
Number of employees in the company Zomedica Corp.
Zomedica supplies diagnostic and therapeutic products to veterinarians. It's a business focused on pet health. This chart shows the size of its team, including sales specialists who work with veterinary clinics and researchers who explore new technologies to improve animal care.
Share of the company's employees Zomedica Corp. within the market segment - Pets
Zomedica develops and markets diagnostic products for veterinarians focused on companion animals. The animal health market is growing rapidly. This chart shows the size of the team Zomedica is building for research, development, and, most importantly, commercialization of its products. This growth reflects its efforts to build a strong sales and distribution network.
Number of employees in the market segment - Pets
Zomedica Corp. is a veterinary company specializing in the development and commercialization of diagnostic and therapeutic products for pets. Its headcount chart reflects the stages of product launch. Growth in the sales and marketing department indicates the beginning of the commercialization of its diagnostic platforms.
Number of employees in the market as a whole
Zomedica aims to conquer the veterinary diagnostics market with its innovative devices. This chart shows the stages of commercialization of its medical equipment. Staff growth, primarily the creation and expansion of a direct sales team, is a key step in promoting products to veterinary clinics and building a sustainable business.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Zomedica Corp. (ZOM)
Zomedica develops and sells diagnostic equipment for veterinarians (for cats and dogs). This business combines R&D (developing new tests) and sales/marketing. This chart shows how the market values their product and technology portfolio. It reflects the market value investors attribute to the potential of their diagnostic platforms per employee.
%20of%20the%20company%20Zomedica%20Corp.%20(ZOM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Zomedica-Corp.-ZOM&v=1772649484520 "Chart of market capitalization per employee (in thousands of dollars) of the company Zomedica Corp. (ZOM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pets
Zomedica Corp. develops and markets diagnostic products for the veterinary market. The company focuses on innovation for pets, combining R&D with commercial operations. This chart shows how the market values their business model in the veterinary medicine niche, calculated per employee.
%20by%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pets&v=1772649484534 "Market capitalization per employee (in thousands of dollars) by market segment - Pets")
Market capitalization per employee (in thousands of dollars) for the overall market
Zomedica Corp. develops and markets diagnostic products for veterinary medicine. This chart shows the company's valuation in the animal health sector. It reflects how the market perceives the potential of its products to improve diagnostics for cats and dogs, a large and rapidly growing market, and how the team is bringing these products to market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772649484545 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Zomedica Corp. (ZOM)
Zomedica is a veterinary company. They sell diagnostic equipment (the Truforma platform) for veterinary clinics. It's a "razor and blades" model. This graph (likely negative) shows how successful this model is. Return on employee revenue depends on sales of consumables for their equipment.
%20Chart%20Zomedica%20Corp.%20(ZOM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Zomedica-Corp.-ZOM&v=1772649484560 "Company Profit Per Employee (in thousands of dollars) Chart Zomedica Corp. (ZOM)")
Profit per employee (in thousands of dollars) in the market segment - Pets
Zomedica is a veterinary company that develops and markets diagnostic products for pets (cats and dogs). Its flagship product is the TRUFORMA platform. This chart shows how successfully the company is commercializing its products. It serves as a benchmark for assessing Zomedica's competitiveness in the growing but competitive market for pet products and services.
%20in%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pets&v=1772649484574 "Chart of profit per employee (in thousands of dollars) in the market segment - Pets")
Profit per employee (in thousands of dollars) for the market as a whole
Zomedica is a veterinary healthcare company. They develop and market diagnostic equipment (the Truforma platform) and therapeutic products for cats and dogs. This chart shows how effectively Zomedica commercializes its R&D per employee working in the animal health technology niche.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772649484582 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Zomedica Corp. (ZOM)
Zomedica Corp. develops and markets diagnostic products for veterinary medicine. This chart shows the commercial success of its products for cats and dogs. The increase in revenue per employee reflects increased sales of diagnostic platforms and cartridges to veterinary clinics, as well as the effectiveness of the sales team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Zomedica-Corp.-ZOM&v=1772649484593 "Sales chart per company employee Zomedica Corp. (ZOM)")
Sales per employee in the market segment - Pets
Zomedica (ZOM) is a veterinary company selling diagnostic equipment (Truforma platform) and therapeutic products for pets (dogs and cats). This is a niche market in medical equipment. This chart shows their commercial performance. ZOM's success depends on the ability of their sales team to convince veterinary clinics to purchase their equipment and supplies.
Sales per employee for the market as a whole
Zomedica is a company that provides diagnostic solutions for veterinarians (for cats and dogs). It's a niche medical business. This metric reflects how effectively their R&D team creates in-demand products, and how effectively their sales team monetizes them by working with veterinary clinics.
Short shares by company, segment and market as a whole
Shares shorted by company Zomedica Corp. (ZOM)
Zomedica (ZOM) is a veterinary company that develops and sells diagnostic equipment (the TRUFORMA platform) for veterinarians to conduct tests directly in their clinics. This indicator measures skepticism. Do the "bears" doubt that veterinarians will buy their equipment en masse, preferring to send their tests to large labs?
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Zomedica-Corp.-ZOM&v=1772649484620 "Short Shares Chart for the Company Zomedica Corp. (ZOM)")
Shares shorted by market segment - Pets
Zomedica is a company operating in the veterinary medicine sector. They develop and sell diagnostic equipment (such as the TRUFORMA platform) for veterinary clinics. This chart illustrates the overall bearish sentiment across the pet products and services sector. It reflects the extent to which investors believe people will continue to spend large sums on pets even in the face of inflation.
Shares shorted by the overall market
Zomedica is a microcap stock trying to sell diagnostic equipment to veterinarians. This chart illustrates the general fear. Although the animal sector is considered "defensive," investors sell off unprofitable small companies during periods of panic. They fear that ZOM is burning through cash and won't be able to return to profitability in a downturn.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Zomedica Corp. (ZOM)
Zomedica (ZOM) is a veterinary company that develops and sells diagnostic equipment (Truforma platform) for clinics. The "pet economy" is growing. This chart measures the strength of speculative moves. It shows when the stock is "overheated" (above 70) on product launch news or "oversold" (below 30) due to slow sales.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Zomedica-Corp.-ZOM&v=1772649484648 "RSI 14 indicator chart for the company's stock Zomedica Corp. (ZOM)")
RSI 14 Market Segment - Pets
Zomedica is "medtech" for *veterinarians*. They make *diagnostic* equipment (TRUFORMA) for *veterinary* clinics ("Point-of-Care"). The "Pets" sector is "eternal." RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is ZOM's growth a niche or a general "hype"?
RSI 14 for the overall market
Zomedica (ZOM), a cash-burning biotech (for pets). This chart is its lifeline. During periods of market euphoria (and pet "booms"), investors are willing to "buy the dream" and fund unprofitable R&D projects. In moments of panic, the cash flow is turned off, and investors flee speculation.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ZOM (Zomedica Corp.)
Zomedica is an animal health company that produces a diagnostic platform (TRUFORMA) for veterinarians. This chart shows the average analyst forecast. Their targets are based on growth in the installed base of TRUFORMA devices and, more importantly, on growth in recurring sales of consumables (cartridges).
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ZOM-Zomedica-Corp.&v=1772649484700 "A chart showing analyst consensus forecasts for the expected stock price. ZOM (Zomedica Corp.)")
The difference between the consensus estimate and the actual stock price ZOM (Zomedica Corp.)
Zomedica is high-tech for veterinarians. The company supplies diagnostic equipment (the TRUFORMA platform) that allows veterinarians to conduct tests *directly* in their clinics. This chart shows how much the current share price differs from the "fair" value. It reflects analysts' faith in their hardware and the trend toward "humanizing" pets.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ZOM-Zomedica-Corp.&v=1772649484717 "A chart showing the difference between the consensus forecast and the actual stock price. ZOM (Zomedica Corp.)")
Analyst consensus forecast for stock prices by market segment - Pets
Zomedica (ZOM) is a company in the veterinary diagnostics sector. It sells devices (Truforma) for in-clinic testing, eliminating the need for veterinarians to wait for lab services. This chart shows analysts' general expectations for the pet products sector. It reflects whether experts believe in the growing "premiumization" of veterinary services.
Analysts' consensus forecast for the overall market share price
Zomedica (ZOM) is a veterinarian's "laboratory." They sell diagnostic devices (the Truforma platform) that allow veterinarians to conduct tests (such as thyroid tests) directly in the clinic. This chart shows the general sentiment of experts. It reflects the analysts' belief that consumers will continue to spend on premium pet health.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Zomedica Corp.
Zomedica is a biotech boutique for veterinarians. Their specialty is diagnostics (Point-of-Care). Their razor is a platform (TRUFORMA) that they install in clinics. Their blades are disposable cartridges (tests) for rapid tests (thyroid, adrenal) in animals. This graph is a summary indicator of their razor and blades. It reflects their (slow) growth of the installed base.
AKIMA Market Segment Index - Pets
Zomedica (ZOM) is all about pet health. They develop and sell diagnostic equipment (the Truforma platform) and medications exclusively for veterinarians. It's veterinary medtech. This chart compares their composite index to the pet sector average.
The AKIM Index for the overall market
Zomedica is a veterinary company offering diagnostic (TRUFORMA) and therapeutic devices for pets. This chart, which reflects the market average, is a backdrop. It helps assess how Zomedica, a consolidator in the fragmented veterinary market, compares to overall macroeconomic trends.
